High-field 3 T imaging of Alzheimer disease

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Alzheimer disease (AD) is a neurodegenerative disease with neuronal loss, leading to dementia and neurological impairment [1]. Metabolic alterations are the basis of histological changes, occurring several years before cognitive impairment. In mild cognitive impairment (MCI) functional disability is absent; conversely, in Alzheimer dementia, disease progression is faster and disability occurs. © 2006 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Luccichenti, G., Péran, P., Cherubini, A., Giugni, E., Scarabino, T., Hagberg, G. E., & Sabatini, U. (2006). High-field 3 T imaging of Alzheimer disease. In High Field Brain MRI: Use in Clinical Practice (pp. 201–207). Springer Berlin Heidelberg. https://doi.org/10.1007/3-540-31776-7_17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free